Atkins, Andrew

Publications

Sort by

Co-Author Network

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy. Frontiers in genome editing. 2021 Review GET IT
Times cited: 42
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy. Frontiers in cellular and infection microbiology. 2021 Academic Article GET IT
Times cited: 8
HIV-1 cure strategies: why CRISPR?. Expert opinion on biological therapy. 2021 Review GET IT
Times cited: 18
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing. Frontiers in microbiology. 2020 Review GET IT
Times cited: 13
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites. Molecular therapy. Nucleic acids. 2020 Academic Article GET IT
Times cited: 14
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. Scientific reports. 2019 Academic Article GET IT
Times cited: 24
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency. Molecular therapy : the journal of the American Society of Gene Therapy. 2019 Academic Article GET IT
Times cited: 21
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection. Frontiers in microbiology. 2018 Review GET IT
Times cited: 49